Cite
Inhibiting glycogen biosynthesis by mTORC1 suppression as an adjunct therapy for Pompe disease
MLA
Moreland, Rodney, et al. “Inhibiting Glycogen Biosynthesis by MTORC1 Suppression as an Adjunct Therapy for Pompe Disease.” Molecular Genetics & Metabolism, vol. 102, no. 2, Feb. 2011, p. S30. EBSCOhost, https://doi.org/10.1016/j.ymgme.2010.11.102.
APA
Moreland, R., Taylor, K., Ashe, K., Meyers, E., Ellis, A., Jingozyan, V., Finn, P., Cheng, S., Klinger, K., Marshall, J., McPherson, J., Mattaliano, R., & Scheule, R. (2011). Inhibiting glycogen biosynthesis by mTORC1 suppression as an adjunct therapy for Pompe disease. Molecular Genetics & Metabolism, 102(2), S30. https://doi.org/10.1016/j.ymgme.2010.11.102
Chicago
Moreland, Rodney, Kristin Taylor, Karen Ashe, Elizabeth Meyers, Allen Ellis, Varvara Jingozyan, Patrick Finn, et al. 2011. “Inhibiting Glycogen Biosynthesis by MTORC1 Suppression as an Adjunct Therapy for Pompe Disease.” Molecular Genetics & Metabolism 102 (2): S30. doi:10.1016/j.ymgme.2010.11.102.